Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-044110
Filing Date
2024-10-29
Accepted
2024-10-29 16:32:57
Documents
14
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A alts-20241029.htm   iXBRL PRE 14A 548113
3 alts-20241029_g1.jpg GRAPHIC 114852
4 alts-20241029_g2.jpg GRAPHIC 132943
  Complete submission text file 0001628280-24-044110.txt   1572443

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alts-20241029.xsd EX-101.SCH 926
16 EXTRACTED XBRL INSTANCE DOCUMENT alts-20241029_htm.xml XML 33732
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19621 | Film No.: 241406239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)